Product Information
BUSPIRONE HCL 10 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0296 per EA under NDC 00378115001. Its NADAC has been published 653 times since Nov 28, 2013.
FDA first approved this application on Mar 28, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378115001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076008FDA Approved
3/28/2001
TE Code
AB
On Market Since
3/21/2002
Price Statistics
The NADAC for BUSPIRONE HCL 10 MG TABLET has been published 653 times since Nov 28, 2013, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0296 per EA |
|---|---|
| All-time high | $0.0742 (Mar 12, 2014) |
| All-time low | $0.0258 (Nov 20, 2024) |
| 52-week high | $0.0316 |
| 52-week low | $0.0293 |
| Median price | $0.0446 |
| Average price | $0.0476 |
| Largest weekly change | +24.0% (Aug 21, 2024) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
0.0%
6M
+1.3%
1Y
-6.2%
3Y
-20.9%
5Y
-24.4%
All
-58.2%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 10 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0296 per EA (NDC 00378115001), effective May 27, 2026.
How has the price of BUSPIRONE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 10 MG TABLET has declined 58.2%. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 10 MG TABLET?
Since Nov 28, 2013, the NADAC for BUSPIRONE HCL 10 MG TABLET has ranged from a low of $0.0258 (Nov 20, 2024) to a high of $0.0742 (Mar 12, 2014), with a median of $0.0446 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 10 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 10 MG TABLET, is $0.0279 per EA — about 6% below BUSPIRONE HCL 10 MG TABLET.
Who manufactures BUSPIRONE HCL 10 MG TABLET?
BUSPIRONE HCL 10 MG TABLET (NDC 00378115001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.